Member Login
  1. Stocks
    2. /
  2. Moderna, Inc. (NASDAQ: MRNA)
    3. /

NASDAQ:MRNA (Moderna, Inc.)

About MRNA

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Moderna, Inc. (NASDAQ: MRNA) Latest News

Syringe and vial on blue background
Investing Articles

Is it time to buy Moderna shares?

| Dr. James Fox

Moderna shares have lost nearly 15% of their value over the last week. So is it time for me to…

Read more »

Investing Articles

Is Moderna stock a buy?

| Dan Appleby, CFA

Moderna stock is rallying after a new strain of the Covid virus was announced. Dan Appleby looks at the company…

Read more »

Investing Articles

What is the Moderna share price really worth?

| Rupert Hargreaves

Rupert Hargreaves explains why he thinks the Moderna share price is attractively priced after the company's recent declines.

Read more »

Investing Articles

I think these 2 S&P 500 stocks are severely overvalued

| Stuart Blair

S&P 500 stocks have soared in recent times, reaching new highs day-by-day. But I now think that these two growth…

Read more »

Young lady working from home office during coronavirus pandemic.
Investing Articles

Should I buy Moderna for my Stocks and Shares ISA?

| Rupert Hargreaves

Rupert Hargreaves explains why he thinks the Moderna share price could be an attractive acquisition for his Stocks and Shares…

Read more »

Syringe and vial on blue background
Investing Articles

Moderna shares are beating the rest of the S&P 500. Am I buying?

| Stuart Blair

Moderna shares have had a fantastic 2021, and have risen far more than the rest of the S&P 500. After…

Read more »

Investing Articles

Can the Moderna share price keep rising?

| Zaven Boyrazian, MSc

The Moderna share price has surged more than 450% in 12 months. But this explosive growth may soon be over.…

Read more »

Investing Articles

The Moderna share price has risen +400%: should I buy the stock now?

| Charlie Keough

With the continued vaccine rollout leading to a positive Q1, Charlie Keough assesses whether he sees long-term value in the…

Read more »

Investing Articles

The Moderna share price: have I missed the boat?

| Jon Smith

After rallying over 300% in the past year, Jonathan Smith offers his opinion on whether the Moderna share price still…

Read more »

Syringe and vial on blue background
Investing Articles

The AstraZeneca share price steadies: is this FTSE 100 stock a good investment?

| Kirsteen Mackay

The AstraZeneca share price is showing resilience in the face of disappointing vaccine publicity. This FTSE 100 stock has a…

Read more »